Literature DB >> 28888133

Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.

Hannah L Itell1, Amitinder Kaur2, Jesse D Deere3, Peter A Barry3, Sallie R Permar4.   

Abstract

Human cytomegalovirus (HCMV) is the leading opportunistic viral infection in solid organ transplant patients and is the most common congenitally transmitted pathogen worldwide. Despite the significant burden of disease HCMV causes in immunosuppressed patients and infected newborns, there are no licensed preventative vaccines or effective immunotherapeutic treatments for HCMV, largely due to our incomplete understanding of the immune correlates of protection against HCMV infection and disease. Though CMV species-specificity imposes an additional challenge in defining a suitable animal model for HCMV, nonhuman primate (NHP) CMVs are the most genetically related to HCMV. In this review, we discuss the advantages and applicability of rhesus monkey models for studying HCMV infections and pathogenesis and ultimately informing vaccine development.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28888133      PMCID： PMC5659282          DOI： 10.1016/j.coviro.2017.08.005

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN： 1879-6257            Impact factor:   7.090


  91 in total

1.  Asymptomatic primary cytomegalovirus infection: virologic and immunologic features.

Authors:  F Zanghellini; S B Boppana; V C Emery; P D Griffiths; R F Pass
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

Review 2.  Insights into viral transmission at the uterine-placental interface.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Takako Tabata
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

3.  Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.

Authors:  Silvia Visentin; Renzo Manara; Laura Milanese; Anna Da Roit; Gabriella Forner; Eleonora Salviato; Valentina Citton; Fioretta Marciani Magno; Eva Orzan; Carla Morando; Riccardo Cusinato; Carlo Mengoli; Giorgio Palu; Mario Ermani; Roberto Rinaldi; Erich Cosmi; Nadia Gussetti
Journal:  Clin Infect Dis       Date:  2012-04-26       Impact factor: 9.079

4.  Use of specific-pathogen-free (SPF) rhesus macaques to better model oral pediatric cytomegalovirus infection.

Authors:  Myra G dela Pena; Lisa Strelow; Peter A Barry; Kristina Abel
Journal:  J Med Primatol       Date:  2012-06       Impact factor: 0.667

Review 5.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Cloning and characterization of rhesus cytomegalovirus glycoprotein B.

Authors:  R H Kravitz; K S Sciabica; K Cho; P A Luciw; P A Barry
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

7.  Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques.

Authors:  J L Huff; R Eberle; J Capitanio; S S Zhou; P A Barry
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

8.  Frequency of human cytomegalovirus-specific T cells during pregnancy determined by intracellular cytokine staining.

Authors:  Tomoko Fujikawa; Kei Numazaki; Hideomi Asanuma; Ryuichi Kudo; Hiroyuki Tsutsumi
Journal:  J Med Virol       Date:  2003-12       Impact factor: 2.327

9.  Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection.

Authors:  D J Anderson; D J Lo; F Leopardi; M Song; N A Turgeon; E A Strobert; J B Jenkins; R Wang; K A Reimann; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2016-01-14       Impact factor: 8.086

10.  Natural Killer Cell Evasion Is Essential for Infection by Rhesus Cytomegalovirus.

Authors:  Elizabeth R Sturgill; Daniel Malouli; Scott G Hansen; Benjamin J Burwitz; Seongkyung Seo; Christine L Schneider; Jennie L Womack; Marieke C Verweij; Abigail B Ventura; Amruta Bhusari; Krystal M Jeffries; Alfred W Legasse; Michael K Axthelm; Amy W Hudson; Jonah B Sacha; Louis J Picker; Klaus Früh
Journal:  PLoS Pathog       Date:  2016-08-31       Impact factor: 6.823
View more
  31 in total

1.  Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.

Authors:  Cody S Nelson; Ilona Baraniak; Daniele Lilleri; Matthew B Reeves; Paul D Griffiths; Sallie R Permar
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

2.  Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

3.  Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.

Authors:  Cody S Nelson; Jennifer A Jenks; Norbert Pardi; Matthew Goodwin; Hunter Roark; Whitney Edwards; Jason S McLellan; Justin Pollara; Drew Weissman; Sallie R Permar
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

Review 4.  Nonhuman primate models of human viral infections.

Authors:  Jacob D Estes; Scott W Wong; Jason M Brenchley
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

5.  Characterization of Baboon Cytomegalovirus Infection in Healthy Adult Baboons (Papio anubis).

Authors:  Erin L Willis; Taylor L Stevens; Gary L White; Dianne Mcfarlane
Journal:  Comp Med       Date:  2019-01-31       Impact factor: 0.982

6.  Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.

Authors:  Richard Kiener; Markus Fleischmann; Marian Alexander Wiegand; Niels A W Lemmermann; Christiane Schwegler; Christine Kaufmann; Angelique Renzaho; Simone Thomas; Eva Felder; Hans Helmut Niller; Benedikt Asbach; Ralf Wagner
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 7.  A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection.

Authors:  Don Jeffrey Diamond; Corinna La Rosa; Flavia Chiuppesi; Heidi Contreras; Sanjeet Dadwal; Felix Wussow; Supriya Bautista; Ryotaro Nakamura; John A Zaia
Journal:  Expert Rev Vaccines       Date:  2018-10-03       Impact factor: 5.217

Review 8.  Cytomegalovirus: Shape-Shifting the Immune System.

Authors:  Gaëlle Picarda; Chris A Benedict
Journal:  J Immunol       Date:  2018-06-15       Impact factor: 5.422

9.  Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy.

Authors:  Daniel Malouli; Scott G Hansen; Meaghan H Hancock; Colette M Hughes; Julia C Ford; Roxanne M Gilbride; Abigail B Ventura; David Morrow; Kurt T Randall; Husam Taher; Luke S Uebelhoer; Matthew R McArdle; Courtney R Papen; Renee Espinosa Trethewy; Kelli Oswald; Rebecca Shoemaker; Brian Berkemeier; William J Bosche; Michael Hull; Justin M Greene; Michael K Axthelm; Jason Shao; Paul T Edlefsen; Finn Grey; Jay A Nelson; Jeffrey D Lifson; Daniel Streblow; Jonah B Sacha; Klaus Früh; Louis J Picker
Journal:  Sci Immunol       Date:  2021-03-25

Review 10.  Non-human Primate Models to Investigate Mechanisms of Infection-Associated Fetal and Pediatric Injury, Teratogenesis and Stillbirth.

Authors:  Miranda Li; Alyssa Brokaw; Anna M Furuta; Brahm Coler; Veronica Obregon-Perko; Ann Chahroudi; Hsuan-Yuan Wang; Sallie R Permar; Charlotte E Hotchkiss; Thaddeus G Golos; Lakshmi Rajagopal; Kristina M Adams Waldorf
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.